Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 3,588,639 $ 8,224,508
Prepaid expenses and other current assets 2,926,202 2,976,583
Total Current Assets 6,514,841 11,201,091
Intangible assets, net 1,564,860 1,948,913
In-process research and development 12,290,516 12,575,780
Goodwill 13,965,715 36,987,886
Total Assets 34,335,932 62,713,670
Current Liabilities:    
Accounts payable 1,015,244 586,611
Accrued expenses 2,092,029 1,964,580
Accrued expenses - related parties 158,467 18,370
Loans payable - current portion 321,694 1,828,079
Loans payable - related parties 84,756 81,277
Derivative liabilities 1,052,807 15,220,367
Total Current Liabilities 4,724,997 19,699,284
Loans payable – non current portion 31,522 48,165
Deferred tax liability 3,504,046 3,643,526
Total Liabilities 8,260,565 23,390,975
Commitments and contingencies (Note 8)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; (see designations and shares authorized for Series A, Class C and Class K preferred stock)
Class C Preferred Stock; 1 share authorized, issued and outstanding at September 30, 2022 and December 31, 2021
Class K Preferred Stock; 1 share authorized, issued and outstanding at September 30, 2022 and December 31, 2021
Common stock, $0.0001 par value; 100,000,000 shares authorized; 39,246,011 and 34,035,925 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 3,924 3,404
Additional paid-in capital 115,427,474 107,184,137
Accumulated other comprehensive (loss) income (3,689,764) 817,440
Accumulated deficit (85,666,267) (68,682,286)
Total Stockholders’ Equity 26,075,367 39,322,695
Total Liabilities and Stockholders’ Equity $ 34,335,932 $ 62,713,670